148 related articles for article (PubMed ID: 9554442)
1. Retinoic acid receptor beta expression and growth inhibition of gynecologic cancer cells by the synthetic retinoid N-(4-hydroxyphenyl) retinamide.
Sabichi AL; Hendricks DT; Bober MA; Birrer MJ
J Natl Cancer Inst; 1998 Apr; 90(8):597-605. PubMed ID: 9554442
[TBL] [Abstract][Full Text] [Related]
2. Role of retinoic acid receptor overexpression in sensitivity to fenretinide and tumorigenicity of human ovarian carcinoma cells.
Pergolizzi R; Appierto V; Crosti M; Cavadini E; Cleris L; Guffanti A; Formelli F
Int J Cancer; 1999 May; 81(5):829-34. PubMed ID: 10328240
[TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by fenretinide (4HPR) in human ovarian carcinoma cells and its association with retinoic acid receptor expression.
Supino R; Crosti M; Clerici M; Warlters A; Cleris L; Zunino F; Formelli F
Int J Cancer; 1996 Feb; 65(4):491-7. PubMed ID: 8621233
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of cancer cell growth by all-trans retinoic acid and its analog N-(4-hydroxyphenyl) retinamide: a possible mechanism of action via regulation of retinoid receptors expression.
Liu G; Wu M; Levi G; Ferrari N
Int J Cancer; 1998 Oct; 78(2):248-54. PubMed ID: 9754659
[TBL] [Abstract][Full Text] [Related]
5. 4HPR triggers apoptosis but not differentiation in retinoid sensitive and resistant human embryonal carcinoma cells through an RARgamma independent pathway.
Kitareewan S; Spinella MJ; Allopenna J; Reczek PR; Dmitrovsky E
Oncogene; 1999 Oct; 18(42):5747-55. PubMed ID: 10523855
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxyphenyl retinamide is a highly selective activator of retinoid receptors.
Fanjul AN; Delia D; Pierotti MA; Rideout D; Yu JQ; Pfahl M
J Biol Chem; 1996 Sep; 271(37):22441-6. PubMed ID: 8798408
[TBL] [Abstract][Full Text] [Related]
7. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.
Sun SY; Li W; Yue P; Lippman SM; Hong WK; Lotan R
Cancer Res; 1999 May; 59(10):2493-8. PubMed ID: 10344763
[TBL] [Abstract][Full Text] [Related]
8. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells.
Oridate N; Suzuki S; Higuchi M; Mitchell MF; Hong WK; Lotan R
J Natl Cancer Inst; 1997 Aug; 89(16):1191-8. PubMed ID: 9274913
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells.
Sun SY; Yue P; Lotan R
Mol Pharmacol; 1999 Mar; 55(3):403-10. PubMed ID: 10051523
[TBL] [Abstract][Full Text] [Related]
10. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines.
Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R
Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596
[TBL] [Abstract][Full Text] [Related]
11. Retinoid receptor-dependent and -independent effects of N-(4-hydroxyphenyl)retinamide in F9 embryonal carcinoma cells.
Clifford JL; Menter DG; Wang M; Lotan R; Lippman SM
Cancer Res; 1999 Jan; 59(1):14-8. PubMed ID: 9892176
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid- and N-(4-hydroxyphenil)-retinamide-induced growth arrest and apoptosis in orbital fibroblasts in Graves' disease.
Pasquali D; Bellastella A; Colantuoni V; Vassallo P; Bonavolontà G; Rossi V; Notaro A; Sinisi AA
Metabolism; 2003 Nov; 52(11):1387-92. PubMed ID: 14624395
[TBL] [Abstract][Full Text] [Related]
13. Identification of retinamides that are more potent than N-(4-hydroxyphenyl)retinamide in inhibiting growth and inducing apoptosis of human head and neck and lung cancer cells.
Sun SY; Yue P; Kelloff GJ; Steele VE; Lippman SM; Hong WK; Lotan R
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):595-601. PubMed ID: 11401908
[TBL] [Abstract][Full Text] [Related]
14. Nuclear retinoid receptors are involved in N-(4-hydroxyphenyl) retinamide (Fenretinide)-induced gene expression and growth inhibition in HL-60 acute myeloid leukemia cells.
Ozpolat B; Tari AM; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2004 May; 45(5):979-85. PubMed ID: 15291358
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of GADD153 expression in the apoptotic signaling of N-(4-hydroxyphenyl)retinamide (4HPR).
Xia Y; Wong NS; Fong WF; Tideman H
Int J Cancer; 2002 Nov; 102(1):7-14. PubMed ID: 12353227
[TBL] [Abstract][Full Text] [Related]
16. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
17. N-(4-hydroxyphenyl)retinamide induces apoptosis in human retinal pigment epithelial cells: retinoic acid receptors regulate apoptosis, reactive oxygen species generation, and the expression of heme oxygenase-1 and Gadd153.
Samuel W; Kutty RK; Nagineni S; Vijayasarathy C; Chandraratna RA; Wiggert B
J Cell Physiol; 2006 Dec; 209(3):854-65. PubMed ID: 16972258
[TBL] [Abstract][Full Text] [Related]
18. Cross-resistance to the synthetic retinoid CD437 in a paclitaxel-resistant human ovarian carcinoma cell line is independent of the overexpression of retinoic acid receptor-gamma.
Kumar A; Soprano DR; Parekh HK
Cancer Res; 2001 Oct; 61(20):7552-5. PubMed ID: 11606393
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of retinoic acid receptor beta induces growth arrest and apoptosis in oral cancer cell lines.
Hayashi K; Yokozaki H; Naka K; Yasui W; Lotan R; Tahara E
Jpn J Cancer Res; 2001 Jan; 92(1):42-50. PubMed ID: 11173543
[TBL] [Abstract][Full Text] [Related]
20. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
Zou C; Liebert M; Zou C; Grossman HB; Lotan R
J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
